Announcement AuMEGA Metals Provides Exploration Update In its 29 July 2025 announcement, AuMEGA Metals Ltd (ASX: AAM | TSXV: AUM | OTCQB: AUMMF) delivered a substantial mineral exploration update covering three major Canadian projects—Cape Ray, Bunker Hill, and Hermitage. With a fully funded program and a strong C$9.2 million treasury, AuMEGA is aggressively expanding its data-driven strategy across Newfoundland’s Cape Ray Shear Zone, Canada’s largest known gold-bearing structure (Figure 1). Figure 1: Historic surficial geochemical footprint and pit shell outlines. (source: AAM) This update underscores the company’s technical shift under new leadership, focusing on systematic geochemical mapping, targeted diamond and RC drilling, and efficient resource extension strategies to maximise discovery opportunities. 1. Key Mineral Exploration Highlights & Summary – Cape Ray Project Phase One Diamond Drilling Completed: A total of 2,559.7 metres drilled across nine holes targeting extensions of Central Zone and Window Glass Hill. Initial assays are expected in mid-August 2025 (Figure 2). Figure 2: Cape Ray 2025 Drill Program – Phase One (source: AAM) Largest Till Geochemistry Program Ever at Cape Ray: Approximately 1,500 till samples being collected across 16 km² at Cape Ray West to integrate with recent airborne EM and magnetics data, refining future drill targets (Figure 3). Figure 3: Cape Ray West Till and Rock Sampling Program (source: AAM) Resource Base: Cape Ray currently hosts 420 koz of Indicated and 141 koz of Inferred gold resources at 2.25g/t and 1.44g/t Au, respectively. Modern Approach: EM survey completed in May 2025 with interpretation underway, designed to find geophysical signatures analogous to known deposits. 2. Key Mineral Exploration Highlights & Summary – Bunker Hill ⮞ Winter Drilling Program: 147 RC holes (1,397m) and 15 diamond drill holes (3,673.25m) completed. One intercept (CRD396) returned 1.84g/t Au over 1m, highlighting the Branch Fault as a key structural feature (Figure 4). Figure 4: 2025 Winter Drill Program at Bunker Hill (source: AAM) No Significant High-Grade Intersections Yet: While assays yielded strong geological insights, no material intersections were recorded in this phase. Follow-up drilling deferred to late Q3 or early Q4 2025. Geochemical Till Sampling to Direct Next Drill Phase (Figure 5): Bunker Hill West: Over 600 till samples across 19 km². Bunker Hill Central: 3,800 samples across 56 km², covering Branch Fault and Nitty Gritty targets. Figure 5: 2025 Bunker Hill Sampling Program (source: AAM) 3. Key Mineral Exploration Highlights & Summary – Hermitage Largest Program in Hermitage History: Over 1,700 geochemical till samples to be collected in Q3 2025, targeting known high-grade anomalies identified through historical airborne magnetic surveys and prior surface work (Figure 6). Figure 6: 2025 Hermitage till geochemical sampling and mapping program (source: AAM) Systematic Coverage: The program will prioritise the central region of Hermitage, where 2023–2024 sampling and magnetic results suggested strong gold prospectivity. Managing Director and CEO, Sam Pazuki, Commented: “We have further enhanced our exploration program—one that is now more focused, more data-driven, and designed to maximise return on investment and unlock shareholder value… We are now addressing resource growth potential beyond pit shells, which historically had limited step-out work. I’m genuinely excited about what lies ahead.” Samso Concluding Comments AuMEGA Metals’ latest exploration update is showing the focus of the company and maintaining its exploration standards. The transition from broad scout-style programs to methodical, data-led exploration is part of the mineral exploration process so there is nothing going waywards. The programs at Cape Ray, Bunker Hill, and Hermitage are coordinated, technically robust, and backed by a clear understanding of structural controls and glacial overburden challenges that have previously limited discovery in the region. This recalibration reflects a more disciplined and potentially more rewarding approach. The decision to aggressively pursue till geochemistry across three high-priority projects signals a company that is using what it has learnt from its exploration programs which is a good sign that they are progressing well as they refine the cost-efficiency of geochemical vectors ahead of drilling. With 1,500 samples at Cape Ray West, 4,400 across Bunker Hill West and Central, and another 1,700 at Hermitage, AuMEGA is laying down a data framework that should significantly de-risk its future drill targeting. This is how discoveries are normally and historically made—by narrowing the field with science before deploying the drill bit. While assay results from recent drilling were mixed—especially at Bunker Hill—the context is important. These were largely exploratory holes designed to build structural understanding, not necessarily to deliver headline grades. I like the fact that AuMEGA is playing the long game, leveraging its strong treasury and strategic landholding to build a case for potential resource expansion and new discovery. This is a smart use of capital and time in an environment where cost control and exploration efficiency matter more than ever. Figure 7: The AAM share price chart as of 5th August 2025. (source: commsec). For ASX investors looking at the gold space, AuMEGA stands out as a junior with serious intent, a well-funded budget, and a pipeline of quality targets. The company’s 110 km of tenure along the Cape Ray Shear Zone—including areas adjacent to Equinox Gold’s multi-million-ounce Valentine Project—offers clear leverage to discovery success. With strong institutional backing, technical credibility, and a proactive exploration model, AuMEGA is one to watch closely in the second half of 2025. The share price chart in Figure 7 looks like its on a holding pattern which is a good sign that the market is patient. This is a big company exploration play and for those investors who are patient and understand the time for a real exploration discovery will hang around. A market capitalisation of AUD $24.84M is a good number. I want to remind readers of the success of Gold Road Resources was all about exploration success with patience so take note. For those who are interested in the Gold Road Resources story and the discovery of the Gruyere Gold Deposit, check it out here: Cover photo: Cetate open-pit gold mine, István Mihály. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Cetate_open-pit_gold_mine.jpg) The Samso Way – Seek the Research Understanding early-stage exploration stories like AuMEGA’s means going beyond headline intercepts. It’s about scale, targeting strategy, funding strength, and leadership. At Samso, we follow explorers who build data-rich, geologically sound roadmaps toward discovery, and AuMEGA is doing just that. Keep watching as the next assay sets come in and the drill rigs return later in the year. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement Completion of Acquisition and Operational Update Avira Resources Ltd (ASX: AVW) has made a number of announcements over the past several months that suggest a period of repositioning. While not a traditional IPO in the sense of a new listing, the company has completed a capital restructuring, including an Options Prospectus, and appears to be preparing for a more active exploration season in 2025. This article pulls together key developments from their recent announcements to give readers a clearer picture of where the company is headed and what has changed since the start of the year. 🔷The Tangadee Story – What’s on the Ground - Copper - Nickel - Zinc According to Avira’s latest announcements, the company now holds three exploration licences in the Ashburton Region of Western Australia (Figure 1): E52/4411 E52/4439 E52/4413 Figure 1: Location of the Tangadee Project in the Ashburton region of Western Australia (source: Avira Resources Limited) These three tenements, collectively called the Tangadee Project, span 779 km² and are described as having potential for sediment-hosted Cu-Zn sulphide and magmatic Cu-Ni sulphide mineralisation. The project lies across the faulted contact of the Edmund and Collier Basins in the Capricorn Orogen, an area that has attracted several explorers, including Teck Australia, Dreadnought, Bellavista, Miramar, and Greatland Exploration (Figure 2). Figure 2: Explorers are currently active within the vicinity of Avira’s Tangadee Project area(source: Avira Resources Limited) The company has identified three late-time EM conductors from historical VTEM surveys (2018, 2023) (Figure 3). These are the basis for their initial drill targeting. According to the company, no previous drilling has been carried out across these tenements. Historic lag samples have returned up to 1080 ppm Cu and 190 ppm Cu with 560 ppm Pb from GSWA samples. Figure 3: E52/4411: Summary of historical exploration and location of EM Target 1 on VTEM image (source: Avira Resources Limited). Avira has stated that fieldwork is planned for mid-2025, including access assessments, mapping, and consultation with native titleholders. This will precede potential drill testing of the EM conductors—Targets 1, 2, and 3—which are situated near the Mount Vernon Fault and in structurally complex fold hinge zones. 🔷 What’s Happening in Sweden – The Puolalaki Project Avira also holds an exploration permit in Sweden known as the Puolalaki Project, located in the Gällivare mining district. The project contains both Nickel-Copper sulphide mineralisation and zones of gold ± Cu-W-Mo mineralisation, based on historical exploration by LKAB and others. In late 2023, the company intersected high-grade gold at the base of hole PUO23005, which was originally targeting a deep EM conductor. This led to a reassessment of the gold potential. According to Avira, discussions are currently ongoing with a Swedish-based gold explorer regarding a potential farm-out, but no binding agreement has been entered into as of the latest updates. The company has indicated that while these discussions are preliminary, they are part of a broader strategy to realise value from the project without overextending internal resources. 🔷 Corporate Activity – Options and Placements - A Copper - Nickel - Zinc Corporate Investment with A Deeper Meaning? In February 2025, Avira issued a Prospectus offering up to 48,435,500 new AVWOB options at $0.001 each, exercisable at $0.015 on or before 30 June 2027. This was a follow-on from the expiry of a previous series of options (AVWOA) and appears to have been designed to provide long-term optionality for existing holders. In March and April 2025, Avira also announced a $506,000 placement in two tranches, priced at $0.007 per share, with 1-for-1 free attaching AVWOB options. Tranche 1 raised ~$253,000 and was completed on 4 April 2025. Tranche 2 and the associated options remain subject to shareholder approval. These moves suggest a capital strategy that aims to maintain optionality while minimising dilution, particularly during early-stage exploration activities. This is a typical Corporate investment that may be laying the groundwork for the pathway to increase shareholder value. What readers need to understand is that this is a Copper-Nickel-Zinc story that is required for corporate investment activities to create the company narrative that will drive the story. 🔷 Management’s Strong Hand David Deloub (Executive Director): 20+ years in finance and public company management; focuses on strategy and corporate structuring. David Wheeler (Non-Executive Chairman): Brings decades of board experience across ASX-listed entities; provides governance oversight. James Robinson (Non-Executive Director): Background in legal structuring and commercial negotiation. Capital Approach: Fundraising appears to be deliberately modest and timed around key project developments. Project Strategy: According to announcements, technical efforts are focused on untested EM conductors and ground with known anomalies. Governance Style: Decisions to explore farm-outs and carefully staged placements suggest a cautious and structured approach. Samso Concluding Comments Avira Resources (ASX: AVW) is working on repositioning themselves. The company appears to have reframed its direction, particularly with the Tangadee Project. Technically and geologically, from what they’ve shared, the area hasn't seen much in terms of previous drilling, yet the presence of late-time EM conductors and historical copper anomalies makes it something to watch. It's the kind of ground that, based on their current approach, could reveal more as the work progresses. On the Swedish front, the Puolalaki Project has been a consistent part of the story, and now there seems to be a renewed focus on the gold potential. According to their latest updates, they’re looking into a possible farm-out, which suggests they’re considering different ways to unlock value without stretching internal resources. It’s early days, and there’s no guarantee anything will materialise, but the fact that discussions are underway shows they’re keeping their options open. The most important aspect of this company is that it appears to be a house stock for the CPS Capital Crew. Typically, the projects are coming in to earn equity in the company and from this point of view, I would safely say that this definitely a good DYOR. This is what I would call the perfect Bottom Drawer Investment. The valuation could move very quickly when their timing is set. In the meantime, patience is the name of the game. As always, doing your own research and engaging with the company's available information is the best way to get a feel for where it’s all heading. Cover photo: Pentlandite with pyrrhotite - Pentlandite with pyrrhotite from Cobalt, Ontario, Darla Sondrol. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Pentlandite_with_pyrrhotite_(GeoDIL_number_-_1209).jpg) The Samso Way – Seek the Research Here at Samso, we pride ourselves on delivering content for investors that is independent and informed by over three decades of experience in the industry. We are always asking the questions that may sound simple and irrelevant, but these are typically the ones that make sense to you, the one seeking the knowledge. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso News Samso Insights There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement MESOBLAST MAINTAINS MOMENTUM WITH FDA ON ACCELERATED APPROVAL PATHWAY FOR REVASCOR® IN ISCHEMIC HEART FAILURE AND LABEL EXTENSION FOR RYONCIL® IN ADULTS WITH GVHD Mesoblast Limited (ASX:MSB; Nasdaq:MESO), the recognised global developer of allogeneic cellular medicines, has released an important update that reflects both regulatory momentum and commercial progress across its core programs in inflammatory diseases. The company has reaffirmed its strategic positioning with the U.S. Food and Drug Administration (FDA), achieving key milestones across two flagship products—Revascor® and Ryoncil®. FDA Alignment on Accelerated Pathway for Revascor® In early June, Mesoblast engaged the FDA in a Type B meeting under the Regenerative Medicines Advanced Therapy (RMAT) designation for Revascor® (rexlemestrocel-L). This discussion centred on progressing toward a potential Biologics License Application (BLA) for Revascor in patients with ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation. There was general alignment with FDA on critical filing elements, including: Chemistry, manufacturing & controls (CMC). Potency assays required for commercial product release. Confirmatory trial design and primary endpoints post-approval. Mesoblast is now awaiting formal minutes from the FDA meeting to determine its next steps and timeline for potential BLA submission. Ryoncil®: Expansion into Adult GvHD Market Underway Ryoncil® (remestemcel-L-rknd), already FDA-approved for paediatric use in steroid-refractory acute graft versus host disease (SR-aGvHD), is now progressing toward label extension into the adult patient population. A pivotal clinical trial is planned in collaboration with the NIH-funded Bone Marrow Transplant Clinical Trials Network (BMT-CTN), with meetings scheduled for early July. This advancement, if successful, would make Ryoncil® the only FDA-approved mesenchymal stromal cell (MSC) therapy for both paediatric and adult SR-aGvHD indications. Commercial Uptake and Coverage Milestones for Ryoncil® Since its commercial availability on 28 March 2025, Ryoncil® has exceeded internal expectations across all key uptake metrics: Over 20 transplant centres are expected to be onboarded by quarter-end. The therapy is now covered for over 220 million insured lives across the U.S. 37 of 51 states already provide Medicaid coverage via orphan drug lists or medical exception pathways. By 1 July 2025, Ryoncil® will be covered across all 24 million remaining Medicaid lives, ensuring nationwide reimbursement access. Chief Executive Dr. Silviu Itescu commented, “We are very pleased with the momentum of interactions with FDA on both our cardiac and GvHD programs. We are also encouraged by the strength of the Ryoncil® commercial launch, the rate of hospital onboarding, physician adoption, and payor coverage exceeding our expectations in the ten weeks since commercial launch.” An update on product sales is expected in the company’s quarterly activities report at the end of next month. About Mesoblast – Platform, Manufacturing and Global Reach - Cellular Therapies. Mesoblast continues to lead in developing off-the-shelf cellular therapies based on mesenchymal lineage cells. These products are designed to address severe inflammation by releasing targeted anti-inflammatory signals that regulate multiple immune pathways. RYONCIL® is the first and only FDA-approved MSC therapy, currently indicated for paediatric SR-aGvHD and under further development for adult GvHD and inflammatory bowel disease. Revascor® is in advanced development for ischemic heart failure and chronic low back pain. The company has established strategic partnerships across Japan, Europe, and China. Mesoblast also maintains a robust global IP portfolio of over 1,000 patents and applications, ensuring commercial protection into at least 2041. Their proprietary manufacturing enables industrial-scale production of cryopreserved, globally deployable, cell-based medicines. Samso Concluding Comments What’s worth noting is how Mesoblast has quietly navigated two highly demanding regulatory and commercial landscapes simultaneously. The alignment with the FDA on Revascor® is not a green light, but it is certainly a promising signal. When regulators and companies find common ground on CMC and endpoint design, it’s often a sign of substantial groundwork already in place. The early uptake and payer support for Ryoncil® speak to both a clear medical need and execution from the Mesoblast team. That 37 states already provide Medicaid support, and full U.S. state-level coverage is expected by July, shows the company’s discipline in working through reimbursement channels—a process that many underestimate in terms of difficulty and time. While the actual sales figures for Ryoncil® remain to be seen, the groundwork has been laid for commercial traction. If Mesoblast can deliver continued uptake and demonstrate durable outcomes across both adult and paediatric GvHD cases, it may significantly strengthen its standing not only with the FDA but in global therapeutic markets. For investors and followers of the cellular medicine space, this latest update from Mesoblast may be one to bookmark. As always, the true story will be told in data and uptake—but for now, there’s tangible progress to acknowledge. Cover photo: Pipette 0,5 ml nah, Lysippos. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Pipette_0,5_ml_nah.jpg) The Samso Way – Seek the Research At Samso, we encourage investors to look beyond the headlines and focus on the foundations of value—geology, strategy, and execution. Pivotal Metals (ASX: PVT) is a clear example of why this matters. The Company’s systematic approach at the early-stage Lorraine project—highlighted by bonanza-grade gold, emerging gabbro-hosted sulphide targets, and newly defined magnetic corridors—signals a much larger mineral system at play. For those who value method over hype, PVT is one to research now and follow closely as the exploration story builds. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement $8m FY25 Revenue Result Achieved up 86% vs FY24; Launches Flavoured Taki Mai Kava Shots on Amazon USA The Calmer Co. International Limited (ASX: CCO) has delivered a standout FY25 performance, underpinned by strong revenue growth and strategic product expansion. With a preliminary unaudited revenue result exceeding AU$8 million—an 86% increase on FY24—the company continues to gain traction as a leader in the natural relaxation and alcohol-alternative space. At the heart of this momentum is the company's latest move: the launch of flavoured Taki Mai® Kava Shots on Amazon USA. This product expansion is a clear signal of CCO’s intent to deepen its presence in the lucrative US market while growing its ready-to-drink (RTD) portfolio. Zane Yoshida, Founder & CEO of The Calmer Co, commented: “Crossing AU$8 million in revenue for FY25 is a landmark achievement and reflects the strength of our multichannel strategy and the dedication of our team. Our new flavoured kava shots deliver on consumer demand for taste, convenience, and functionality as we continue to scale globally.” 🔷 Key Highlights – FY25 and Strategic Milestones 💠 Revenue Growth: FY25 revenue exceeded AU$8 million, a significant increase from AU$4.3 million in FY24 and a 153% increase from AU$1.7 million in FY23. 💠 Channel Mix: Direct-to-Consumer: 39% Retail: 30% Amazon USA: 23% Wholesale: 8% 💠 National Retail Presence: Coles: Taki Mai® Kava Shots in 797 stores; 150g FijiKava® Instant Kava in 801 stores. Woolworths: National launch of 50g FijiKava® Instant Kava, now available in over 1,100 stores. This rollout has secured more than 35% of the national market share. 💠 Amazon USA Momentum: Subscriptions now account for 28% of Amazon's sales, indicative of strong brand loyalty. Taki Mai® brand share grew from 6% in January to 24% by April 2025. Amazon projects a 45% uplift in kava sales over the next year. 💠 Wholesale Expansion: Growth with IMCD and entry into the US kava bar market via a new partnership with Leilo. 💠 Product Mix Shift: RTD formats now contribute 7.3% of revenue, with further growth expected following the flavoured kava shots launch. 🔷 Flavoured Taki Mai® Kava Shots – A Strategic Digital Play for Kava Distribution. In a move tailored to US consumers, The Calmer Co. has launched five new flavoured kava shots: 1. Flavours: Coconut, Choc Banana, Guava, Pineapple, Mango 2. Formats: 6-pack (single flavour) and 10-pack (mixed flavour) 3. Channel: Initially exclusive to Amazon USA, with rollout to direct digital channels planned These 2.5oz (75ml) RTD shots are designed to meet rising US consumer demand for natural, alcohol-free functional beverages. The launch also aligns with global consumer trends favouring wellness and convenience. Andy Burger, Head of E-commerce at The Calmer Co, commented: “Flavoured kava shots are an exciting step forward for our US digital strategy. These new formats give consumers even more ways to enjoy kava. With Amazon subscriptions and customer retention growing, we’re confident this launch will build strong momentum through our online channels.” Samso Concluding Comments The FY25 revenue result is more than just a number—it’s a signal that The Calmer Co is successfully executing a vision in a high-growth category. From a modest AU$1.7 million in FY23 to over AU$8 million in FY25, the trajectory shows disciplined channel development and product innovation. The company’s Amazon performance is particularly telling. Subscription uptake and growing brand share indicate sticky demand. This is key for investors—loyal, repeat customers are often the backbone of e-commerce profitability. What’s also worth noting is the expansion of RTD formats, a segment that combines convenience, wellness, and flavour. As the flavoured kava shots gain traction, expect this category to become a larger slice of the revenue pie—and possibly a new brand differentiator. Calmer Co Limited Share Price Chart as of 7th July 2025. (source: Commsec) Calmer Co is still below an AUD $10M market capitalisation, which makes this still a very compelling stock for a position. The increasing revenue and the success of getting products into Coles and Woolworths is a significant step. The share price is still looking steady (see above). Finally, for those tracking small caps that are building real businesses with international potential, I feel that CCO stands out as one to watch. Its blend of branding, digital strategy, and product pipeline shows promise in a consumer landscape shifting towards natural, functional alternatives. In the world of Instagram and TikTok, the Kava branding is perfect for that form of advertising. Cover photo: Wheat harvest on field, U.S. Department of Agriculture. Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Wheat_harvest_on_field.jpg) The Samso Way – Seek the Research The Calmer Co. (ASX: CCO) is showing how niche health products when paired with smart digital strategy and retail reach, can scale into a global growth story. With strong revenue momentum and a clear push into the US market, this is a company quietly building long-term value through consistency and consumer insight. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso News Samso Insights There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement AML3D's Largest Custom Arcemy System Online at Austal USA AML3D Expands to UK Defence Market with Alloy Test Contract Investor Presentation - New US defence markets open to AML3D AML3D Expands its Defence Footprint AML3D Limited (ASX:AL3) is forging ahead on its expansion strategy with significant strides into both the United Kingdom and United States defence markets. A recent A$0.83 million contract with BAE Systems UK marks a strategic entry into the UK defence supply chain, with AML3D sourcing 8.5 tonnes of Nickel Aluminium Bronze (NAB) feedstock to support BAE’s feasibility program. This follows sustained relationship-building and signifies the company’s growing credibility in defence manufacturing circles. CEO Sean Ebert emphasized that the BAE Systems contract is just the beginning, forming part of a broader plan to leverage AML3D's advanced manufacturing capabilities from its new US Technology Centre and Adelaide headquarters to support allied defence markets in the UK, Australia, and the US. Sean Ebert, Chief Executive Officer, commented: “AML3D has been developing its relationship with the BAE Systems for over a year. It is very exciting to see that work translate into an initial contract from BAE Systems. It is even more exciting that this contract is planned to be just the first and I look forward to giving updates on additional contracts as the program progress.” “AML3D is moving into the next phase of our growth strategy, which includes leveraging the extraordinary growth and demand we are experiencing within the U.S. Navy’s Submarine Industrial Base to expand into the Australia and the U.K Defence sectors. Beyond this BAE Systems contract, AML3D is developing opportunities with other companies supporting the U.K. Defence sector. And while winning Defence contracts can take time, I am confident that we will be in a position to announce additional orders from the U.K. and Australian defence sectors to compliment the huge momentum we are seeing in the U.S.” Key Highlights AML3D secures its first UK Defence contract with BAE Systems for NAB alloy feedstock supply. Commissioning of the largest custom ARCEMY® system at Austal USA’s Navy AM Center of Excellence. US operations contribute 80% of revenue, now scaling up with A$19M+ in US defence orders to date. Strong cash position of $32.1M post a successful A$30M capital raise in Dec 2024. Clear pathway into broader US and UK defence markets amid escalating interest in additive manufacturing. ARCEMY® Commissioned at Austal USA In parallel, AML3D announced the delivery and commissioning of its largest-ever custom ARCEMY® system at Austal USA, located within the US Navy’s Additive Manufacturing Center of Excellence in Danville, Virginia. This new system—featuring an 11,000kg positioner and a 4m+ linear rail with up to 35m³ build volume—is a milestone in defence-grade additive manufacturing. The deployment reinforces AML3D’s positioning as a technology enabler for the Make Shipbuilding Great Again initiative led by the US Government. Austal USA is central to this movement, with AML3D providing the critical ARCEMY® infrastructure to embed additive manufacturing (AM) into the Navy’s submarine and surface vessel supply chains. Sean Ebert Chief Executive Officer, commented: “The successful delivery [of] the custom ARCEMY® system to Austal USA (refer to ASX announcement November 20, 2023) aligns with our ambitions to expand the range of U.S. defense work we do. AML3D already has a track record of deploying our WAM Additive Manufacturing technology in support of the U.S. Navy submarine industrial base. Those successes are translating to an adoption of additive manufacturing technology in the wider U.S. Marine Industrial Base, covering shipbuilding and munitions.” “I have recently returned from two weeks in the U.S. While there, I inspected our new U.S. facility in Ohio and met with key stakeholders, including U.S. senators, commercial and defense partners and additive manufacturing education and training bodies. The US Government’s ‘Make Shipbuilding Great Again’ initiatives are set to expand, by a factor of three, the potential U.S. Defense markets AML3D’s additive manufacturing technology can address. Additive is now endorsed for use to support US Navy shipbuilding and missile manufacturing. These are markets AML3D already had plans to access directly and through our relationships with key suppliers to the US Navy Marine Industrial base, such as Austal USA.” “There is increasing confidence within the U.S. defense and commercial sectors in additive manufacturing’s ability to address supply chain constraints and significantly improve supply chain efficiency and quality. This, in turn, gives me great confidence that AML3D will see an acceleration in U.S. Defence contract wins and further success in accessing additional sectors such as U.S. Utilities, Aerospace and Oil and Gas.” Strong Financial and Strategic Positioning AML3D reported a 206% revenue increase to $4.63 million for 1H FY2025, with a corresponding 372% rise in gross profit to $3.37 million, largely driven by its US defence contracts. The company’s normalised EBITDA loss narrowed significantly to just $0.17 million. Following an A$30M capital raise in late 2024, AML3D closed the year with $32.1 million in cash, placing it in a strong position to scale its US and UK operations. The US Technology Center in Stow, Ohio is already fulfilling US Navy Submarine Industrial Base orders. AML3D’s relationship with BlueForge Alliance, a strategic procurement partner of the US Navy, continues to deepen following a US$951 million DoD contract awarded to the alliance in 2024. Scaling into Global Defence Ecosystems AML3D's Wire Additive Manufacturing (WAM®) technology is gaining momentum as a disruptive solution to long lead time and high-cost legacy manufacturing. This is particularly vital in defence, where urgent, on-demand supply chains are essential. The company is now actively exploring entry points into guided weapons, hypersonics, naval aviation, and US Army platforms, as well as UK Ministry of Defence projects through its BAE collaboration. Figure 1: WAM® Technology (source: AL3) Through its US subsidiary, AML3D USA Inc., the company has also built high-level bipartisan engagement across Congress, the Department of Defense, and AUKUS-focused bodies. Their strategic relationships include Austal, Huntington Ingalls, and the Navy’s training bodies, such as the ATDM and IALR, which are evaluating ARCEMY® as the go-to solution for training next-gen AM operators. Samso Concluding Comments AML3D’s dual momentum in the UK and US defence sectors presents a significant evolution in its growth narrative. What stands out is not just the contract values, but the strategic positioning—becoming embedded in critical defence supply chains and aligned with national-level manufacturing policy. These are early but strong signals that AML3D’s WAM® platform is being viewed as both viable and scalable. From a Samso point of view, the recent BAE Systems contract may seem small in dollar terms, but its real value lies in the doors it opens. Meanwhile, the commissioning of the largest ARCEMY® unit in the US signals the kind of capacity that can meet substantial future demand. The defence sector isn’t known for overnight wins—it’s about credibility, patience, and delivering when it counts. AML3D appears to be ticking those boxes. The team’s boots-on-the-ground presence and bipartisan endorsements in the US show a maturing strategy that understands how to embed technology into policy-driven ecosystems. For investors, this is a story that is transitioning from early-stage validation into one of long-term execution. If AML3D continues on its current trajectory—leveraging its capital, manufacturing footprint, and strategic partnerships—we may be watching the emergence of a new industrial player that’s relevant across the AUKUS landscape and beyond. Figure 2: AML3D share price chart as of 7th July 2025. (source: commsec) The recent announcements have given the share price a boost (Figure 2) and with a current market capitalisation of just under AUD $135M as of the 7th of July 2025, this is still an early stage. If AML3D start getting substantial projects for the US defence agencies, this will be more than a 10-bagger. For shareholders, it will be fingers crossed and toes crossed. As always, this is not investment advice. But for those following the AML3D story, this appears to be a company that is turning interest into contracts and contracts into traction. With a strong balance sheet and a clear growth strategy, it will be one to watch closely as the story continues to gain strategic relevance globally. Cover photo: 31st MXS metals shop new 3D printing capability will save man hours, money (8529140), U.S. Air Force photo by Staff Sgt. Heather Ley. Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:31st_MXS_metals_shop_new_3D_printing_capability_will_save_man_hours,_money_(8529140).jpg) The Samso Way – Seek the Research At Samso, we encourage investors to look beyond the headlines and focus on the foundations of value—geology, strategy, and execution. Pivotal Metals (ASX: PVT) is a clear example of why this matters. The Company’s systematic approach at the early-stage Lorraine project—highlighted by bonanza-grade gold, emerging gabbro-hosted sulphide targets, and newly defined magnetic corridors—signals a much larger mineral system at play. For those who value method over hype, PVT is one to research now and follow closely as the exploration story builds. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and

Announcement High Purity Lupin Oil Extracted from Initial Trials High-Purity Lupin Oil: Early Success in Co-Product Trials Wide Open Agriculture Ltd (ASX: WOA) has announced the successful extraction of high-purity lupin oil from initial processing trials (Figure 1). The milestone represents a significant technical and commercial step forward, offering both a new revenue stream and a path toward maximising the full value of its lupin feedstock. Figure 1: High Purity Lupin oil extracted from the initial trials (source: WOA) WOA’s trial results confirmed that a novel low-cost extraction method, free from chemical and heat treatments, retains the bioactive integrity of the oil. This means a higher-quality oil with longer shelf life—features that align with consumer demands in the clean-label and natural skincare market. More importantly, this new technique is less capital-intensive and more energy-efficient than existing extraction flows. It lays the groundwork for future scalability without requiring significant increases in capex. The company confirmed that the commercialisation timeline remains aligned with guidance shared at the 2025 AGM and Investor Presentation. Natural Ingredients for a Global Skincare Market WOA’s lupin oil is not just a co-product—it’s a potential game-changer in the cosmetics and personal care industry, which is valued globally at over USD $677 billion. Key bioactive compounds found in the extracted oil include Lutein, β-carotene, Oleic acid, Linoleic acid, and β-sitosterol. These compounds deliver a suite of skincare benefits: Antioxidant protection against free radicals Moisturising and barrier support for dry or sensitive skin Skin brightening to reduce pigmentation and acne scarring Improved elasticity through collagen stimulation Anti-inflammatory properties for calming irritated skin These features position lupin oil as a premium, natural anti-aging and restorative ingredient suitable for a broad range of product formulations. Building the ‘Whole of Seed’ Model Lupin oil is envisioned as the first commercialised co-product alongside WOA’s flagship lupin protein isolate. This approach offers strategic benefits—higher revenue per unit of input, shared production costs, and reduced waste. WOA is concurrently working on extracting other co-products such as gamma conglutin and lupin fibre, advancing its long-term goal of full seed utilisation. These developments are expected to be incorporated into an upcoming feasibility study, assessing the economic case for full-scale commercial production. Yaxi Zhan, Non-Executive Chairperson, commented: “This novel extraction technique, which does not use chemical or heat treatment, preserves the key bioactive compounds in the oil and improves the quality and shelf life of WOA’s current lupin protein isolate product, ensuring delivery of a clean, neutral tasting protein that is increasingly in demand from food and beverage manufacturers.” Scaling Up: What’s Next? A larger trial is already in preparation. It will produce sample volumes of lupin oil for customer engagement and market testing across the skincare, personal care, and potentially functional health sectors. In parallel, the company will continue optimisation efforts to increase production efficiency and support the broader commercial rollout of its lupin-based product suite. WOA’s strategic expansion from a core protein business to a vertically integrated ingredient platform reflects a vision for clean, regenerative, and commercially sustainable agriculture. Samso Concluding Comments An interesting development from Wide Open Agriculture with the development of oils. As someone who was involved in the Sandalwood Oil phenomenon, I am very interested in where this is taking Wide Open Agriculture. In the age of direct marketing, innovation from companies is going to make the penetration of markets a lot straightforward. Will it mean that the journey will be easier, that is a good question. If WOA can extract value from every part of their production system, it will make me want more of the business. Lupin oil might sound niche today, but with the right formulation partnerships, WOA could have a compelling product on its hands for a cosmetics sector increasingly leaning toward natural and functional ingredients. I don't know if this will revolutionise the cosmetic industry, but I am happy if they will be part of or add to the existing market. What will Lupin oil mean in terms of uses...etc will be critical. This will definitely be a good topic for discussion when I next talk to Yazi. It is very obvious that there is still work ahead—larger trials, feasibility studies, and market validation—but this is the kind of groundwork that turns innovative R&D into an investable reality. I’ll be watching closely to see how this fits into WOA’s bigger goal of building a whole-of-seed, low-impact ingredient platform. For investors looking at sustainable agrifood companies or the clean beauty supply chain, WOA’s lupin oil initiative is a development worth following. It’s a quiet but meaningful reminder that value often lies in what others throw away—and that’s where WOA might be finding its edge. Cover photo: Merino Sheep (50983026983), Bernard Spragg. NZ from Christchurch, New Zealand. Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Merino_Sheep_(50983026983).jpg) The Samso Way – Seek the Research Here at Samso, we pride ourselves on delivering content for investors that is independent and informed by over three decades of experience in the industry. We are always asking the questions that may sound simple and irrelevant, but these are typically the ones that make sense to you, the one seeking the knowledge. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and

Announcement Additional Partial Response in Pancreatic Cancer Trial. Amplia Gains US Ethics Approval for Pancreatic Cancer Trial. Second Complete Response in ACCENT Pancreatic Cancer Trial. Pathological Complete Response in Pancreatic Cancer Trial. Capital Raising Presentation. Amplia Therapeutics Limited (ASX: ATX) is entering a compelling phase in its clinical journey, as recent announcements reinforce the growing potential of its lead compound, narmafotinib (AMP945), in the fight against advanced pancreatic cancer (Figure 1). With news of two rare and confirmed complete responses emerging from the ongoing ACCENT trial, investors have reason to take notice. These outcomes are not only clinically remarkable—they may signal a turning point in one of oncology’s most difficult indications. Narmafotinib blocks the activity of the FAK protein. Figure 1: Narmafotinib blocks critical pathways supporting tumour growth (source: ATX) Narmafotinib (AMP945) is the company’s best-in-class inhibitor of the protein FAK (Focal Adhesion Kinase). FAK, a protein—an enzyme that plays a critical role in cancer growth, disease spread, and the formation of fibrotic (scar) tissue. FAK is frequently over-expressed and hyperactive in solid tumours, and elevated levels are strongly associated with poorer patient outcomes. By targeting and blocking FAK activity, narmafotinib reduces cancer progression both within cancer cells and across the tumour microenvironment. ACCENT Trial Delivers Rare Complete Responses The ACCENT clinical trial is a Phase 1b/2a multicentre, open-label study evaluating narmafotinib in combination with gemcitabine and Abraxane® in first-line patients with advanced pancreatic cancer (Figure 2). Initially focused on dose safety and optimisation, the study has progressed into Phase 2a, where efficacy is the key focus. The trial is being conducted at seven sites in Australia and five sites in South Korea. Figure 2: Narmafotinib in combination with standard of care gemcitabine and Abraxane® (source: ATX) On 16 June 2025, Amplia announced that a patient in the trial had achieved a pathological complete response (pCR)—meaning no live tumour tissue was detected following surgical resection of both the primary pancreatic tumour and liver metastases. Just days later, on 19 June, a second patient recorded a confirmed complete response (CR), defined as the total disappearance of all tumour lesions sustained for more than two months. A pathological complete response (pCR) is very rarely reported in patients with advanced pancreatic cancer, where the disease has spread to other organs in the body. In patients with locally advanced (i.e. non-metastatic) pancreatic cancer, however, around 5% of patients do record a pCR in response to treatment with neoadjuvant chemotherapy (chemotherapy before surgery). In these earlier-stage patients, a pCR is associated with improvements in overall survival. These results are statistically rare in metastatic pancreatic cancer. For context, the pivotal MPACT study (NEJM 2013) reported only one CR among 431 patients treated with gemcitabine and Abraxane alone. Amplia’s achievement of two such responses among just 55 trial participants suggests a strong signal of efficacy that warrants continued clinical attention. Regulatory and Clinical Expansion into the US In a parallel development, Amplia has secured Institutional Review Board (IRB) approval in the US to initiate a new Phase 2 clinical trial exploring narmafotinib in combination with FOLFIRINOX. This alternative chemotherapy regimen is the preferred first-line therapy in the United States. This marks a strategic broadening of the company’s development footprint and a critical step in establishing narmafotinib as a globally viable oncology asset. FOLFIRINOX is a chemotherapy cocktail of four drugs used in the treatment of advanced pancreatic cancer, and in the US is the preferred treatment for newly diagnosed patients. The trial is structured as a two-part study and will adhere to the FDA’s Project Optimus framework. Part A will determine the optimal dose of narmafotinib when used with FOLFIRINOX, and Part B will assess safety and efficacy at the recommended dose. Amplia expects to recruit 60–70 patients across up to six US sites and two Australian locations. Dr Chris Burns, Amplia’s CEO and Managing Director, commented: “Receiving the protocol approval from the IRB is a critical step in initiating the US trial of narmafotinib in combination with FOLFIRINOX. Importantly, results from this trial will complement the existing positive data emerging from our current ACCENT trial, aiming to establish narmafotinib as the optimal combination partner for chemotherapy in this challenging disease.” Capital Raising Supports Clinical Acceleration for a Solution to Pancreatic Cancer To fund this expanded pipeline, Amplia launched a capital raising in October 2024 of up to A$13 million. The offer included a pro-rata entitlement offer and institutional placement priced at A$0.115 per share, with attaching options exercisable at $0.1725. Funds raised are being directed toward: Completion of the ACCENT Phase 2a trial Launch and progression of the US-based FOLFIRINOX trial Preclinical R&D and drug manufacturing General working capital and operational support As of 30 September 2024, Amplia had $4.6 million in cash and anticipated an additional $4.0 million in R&D rebates, placing it in a relatively stable position to deliver key trial milestones in 2025. Samso Concluding Comments At Samso, we often talk about the importance of clinical signals that challenge the norms, and Amplia Therapeutics may have just delivered one. In the complex and unforgiving landscape of advanced pancreatic cancer, recording two confirmed complete responses in a small patient cohort is not business as usual. These results, drawn from a well-structured trial using narmafotinib in combination with standard chemotherapy, are giving early shape to what could become a pivotal story in oncology drug development. What makes this even more compelling is the scientific backbone supporting the results. Narmafotinib targets Focal Adhesion Kinase (FAK), a protein increasingly recognised for its role in cancer progression and treatment resistance. By inhibiting FAK, narmafotinib appears to disrupt both the cancer cell’s internal survival mechanisms and the broader tumour microenvironment—an approach that may be enabling chemotherapy to work better, faster, and more durably. This isn’t just another combination trial; it’s a strategic layering of mechanisms backed by translational logic. Amplia’s concurrent move into the US clinical landscape, with FOLFIRINOX as the backbone chemotherapy, is a smart step. It shows not just confidence in the science but also a clear understanding of clinical positioning and market expectations. Layer in their recent capital raise—timed to support both the completion of the ACCENT trial and the launch of the FOLFIRINOX study—and the strategy becomes one of focused execution, not speculative ambition. The additional response to the pancreatic cancer trials is another positive for the company's case for discovery. The additional response brings the objective response rate to 29%. The response data is made up of 6 out of 55 patients enrolled in the trial, with 20 patients still enrolled in the trial. The market is obviously loving the results (Figure 3), and with a market capitalisation of AUD $132M, I would think that there is still plenty of room for expansion. The steep rise in valuation since mid-June is a clear indication that shareholders are excited. Figure 3: Amplia Therapeutics Limited share price chart as of 9th July 2025. (source: commsec) As always, the data will speak for itself in time, but the early indicators are strong. Amplia appear to be staying in their lane and pursuing a high-value therapeutic niche with a well-differentiated molecule. It feels that in the case of looking for a really important topic, such as pancreatic cancer, diversification from this path, for me, would be a sign that they are not focused enough. For clinicians, these complete responses offer hope. And for Samso, this is precisely the kind of story we’re here to track: grounded in science, validated by data, and delivered with clarity. Cover photo: Medical instruments, Saltanat. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Medical_instruments.JPG) The Samso Way – Seek the Research At Samso, we believe that true insights emerge when you look beyond the headlines and into the data that drives conviction. Amplia Therapeutics (ASX: ATX) exemplifies this approach. Their focused pursuit of FAK inhibition in hard-to-treat cancers is backed by rigorous science, translational depth, and early clinical results that are breaking through expectations. The company’s recent clinical milestones in pancreatic cancer are not just updates—they are signals worth dissecting. This is why we say: Seek the Research. Because it’s in the fine print of well-run trials and the clarity of execution where the most compelling stories often begin. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement Completion of reconnaissance program with further natural rutile observed at the Central Rutile Project Thick zones of HM mineralisation observed across Douala High Grade Gallium Potential discovered at Tundulu DY6 significantly expands size of the Central Rutile Project A Trio of Critical Minerals in Motion - Gallium, Rutile and Heavy Mineral Sands. DY6 Metals (ASX: DY6) is pushing forward on multiple fronts across its African exploration portfolio, with material updates out of Malawi and Cameroon. The company is advancing a three-pronged strategy that spans gallium and rare earths at the Tundulu Project in Malawi, and natural rutile and heavy mineral sands (HMS) across the Central Rutile and Douala Basin Projects in Cameroon. Currently, at the early stage of the projects, each program is delivering early signals that suggest technical merit. DY6’s approach appears credible—driven by existing datasets, reinterpreted mineral systems, and structured reconnaissance—and the latest announcements highlight progress and potential economical discovery, however, as I stressed, this is still very early stages of the work. 🔷 Gallium at Tundulu: Not Just a Rare Earths Project On 29 April 2025, DY6 announced it had uncovered high-grade gallium mineralisation at its Tundulu Project in Malawi (Figure 1). The review of 2014 drill data found that gallium occurs from surface and at depth, with some of the most notable intercepts being: 74m @ 93.26g/t Ga₂O₃, incl. 14m @ 202.79g/t (TU043) 53m @ 72.79g/t Ga₂O₃, incl. 12m @ 145.07g/t (TU011) 30m @ 94.63g/t Ga₂O₃, from surface (TU014) Figure 1: Gallium-TREO correlation plot at Tundulu – shows a potential positive geochemical link (source: DY6) These intercepts also coincide with significant rare earth mineralisation, which reinforces the polymetallic nature of the carbonatite system. According to the company, just 40% of the known target area has been drill-tested, and metallurgical testwork is now underway to assess the recovery potential for gallium alongside REE and phosphate. Given gallium’s importance in electronics, particularly semiconductors and photovoltaic cells, this discovery adds a technical and strategic dimension to the Tundulu story, especially considering China’s dominance in gallium supply. 🔷 Cameroon’s Central Rutile: Rutile Nuggets in the Regolith A week later, on 30 June 2025, DY6 confirmed the completion of its reconnaissance exploration program at the Central Rutile Project in Cameroon (Figure 2). The company reported visible coarse rutile nuggets—up to 4cm in size (Figure 3) within both alluvial and residual settings across all five tenements. The fieldwork involved: 9 auger drill holes 44 channel samples 13 surface grabs 3 stream sediment samples Figure 2: Reconnaissance sampling locations at the Central Rutile project (source: DY6) Technical Consultant, Cliff Fitzhenry, commented: “The reconnaissance programme has been a great success, having identified visual HM and rutile mineralisation across each licence. What we have uncovered at the Bounde licence is particularly exciting. I have never seen rutile nuggets of this size before. Figure 3: A coarse rutile nugget (~4cm) with partial thin secondary ferricrete coating was recovered from residual regolith comprising mainly fine-grained, iron-rich soil and clay near a road cutting at sample site GRMAU0012. (source: DY6) All samples are now being analysed at a laboratory in Cape Town, with assay results expected in the September quarter. If confirmed, the potential exists for saprolite-hosted rutile deposits analogous to Sovereign Metals’ Kasiya project in Malawi—a globally significant discovery in its own right. 🔷 Douala Basin: Heavy Mineral Sands Confirmed Just days prior, on 23 June 2025, DY6 also completed its initial reconnaissance across the Douala Basin HMS Project, located near Cameroon’s Atlantic coast (Figure 4). The Douala Basin consists of six tenements totalling 2,580km² and hosts known paleo-placer dune systems. Highlights from the program include: Thick zones of visually high-grade HMS in auger and channel samples Visible rutile grains recovered from multiple sites Visual HM concentrations of up to 6% in auger holes, notably from the Mbanga and Diwong licences Figure 4: Reconnaissance sampling (hand auger and channel) locations at the Douala Basin HMS project. (source: DY6) The team followed up on historical drilling by Eramet, and the early confirmation of HMS supports the broader thesis of Douala’s placer potential. Laboratory assays will be the next checkpoint, and if grades align with visual estimates, the project could emerge as a scalable HMS asset in a logistically favourable location near the port city of Douala. 🔷 Expansion to Weaver Licences: Central Rutile Project Doubles in Size On 8 July 2025, DY6 announced the acquisition of six new exploration licences, collectively known as the Weaver Project, located immediately south of its existing Central Rutile Project (Figure 5). This expansion more than doubles the project area from 2,124km² to 4,974km². Key highlights include: 100% acquisition of six new licences under valid application Landholding in Cameroon increases to 7,554km², including the Douala Basin project The new tenements are underlain by kyanite-bearing mica schist, the same host geology as the original project area Reconnaissance sampling confirmed fine-grained HM and rutile, with up to 10% HM and 5% rutile in some channel samples During a recent due diligence site visit, DY6 and its technical consultants observed both alluvial and eluvial (residual) sources of rutile and heavy mineral sands (HMS), confirming multiple styles of mineralisation across the project area. Figure 5: Map of Central Cameroon showing DY6’s newly acquired six Weaver licences to the southeast which will be incorporated into the Central Rutile Project together with the company’s original 5 licences. (source: DY6) Executive Chairman, Dan Smith, commented: “The acquisition of this new licence package more than doubles our landholding in this highly prospective area of Central Cameroon. Desktop work as well as a recent due diligence site visit, indicates that the Weaver Project area is underlain by the same favourable geology that we have seen at our existing Central Rutile Project. We are also highly encouraged by the results that Peak Minerals has reported to date from their Minta Project which borders us to the north and look forward to getting back in the field.” Samso Concluding Comments In the business of ASX small-capitalised mineral exploration, DY6 Metals is building a portfolio of critical minerals, which is somewhat unique as most ASX critical mineral stories have developed either as a one-commodity play or a necessary shift forced by the market. DY6 has chosen to be exposed to three globally strategic minerals—gallium, rutile (titanium), and rare earths—across two mineralised provinces in Africa. For the moment, importantly, this exposure is supported by drilling data, field observations, and near-term assay programs. Is it ideal for a small cap company on the ASX? Market narratives normally see that more than one is a distraction. Personally, I think that more than one reduces risks. The gallium discovery at Tundulu could shift investor focus from REEs alone to a broader technology metals story. Meanwhile, the Cameroon rutile portfolio positions DY6 next door to what may become a globally significant rutile province, especially if the Kasiya analogy plays out. Visual confirmation of rutile nuggets and heavy mineral sands across Central and Douala is a promising first step. While assay results will be key in confirming grade and scale, the groundwork is being laid now—methodically, systematically, and to unlock real value. The market likes the story and The market likes the story (Figure 5) and at a current market capitalisation of AUD $15.26M, this is not an expensive "punt". Exciting news on results could give multi-bags for shareholders, from this junction. As we write, the company is in trading halt awaiting news of a potential acquisition. Figure 5: DY6 share price chart as of 4th July 2025. (source: Commsec) From an investor's point of view, this is a good DYOR candidate. I know some of the management and they are seasoned participants in the industry. I do believe that the company will be able to attract some well-versed players into the register, if they are not already in the register. Check out the story and keep your eyes and ears pinned to what is happening here as I think there could be some more upside to come. The Samso Way – Seek the Research This is what early-stage multicommodity exploration often looks like: data reanalysis, ground-truthing, geological intuition, and steady technical milestones. DY6 isn’t just adding buzzwords to a portfolio—it’s pursuing a methodical and evidence-based strategy that unfolds one layer at a time. Gallium, rutile, and HMS each come with their own markets, processing paths, and exploration nuances, and DY6 seems aware of the need to treat each accordingly. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Cover photo: Ilmenite sand, Mx. Granger. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Ilmenite_sand.jpg) Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement Marimaca Drills Pampa Medina Sulphides Marimaca Copper Corp (ASX: MC2 | TSX: MARI) has reported a significant breakthrough in its exploration campaign in the Pampa Medina area, situated 28km east of the Marimaca Oxide Deposit (MOD) (Figure 1). The standout result is a spectacular 6m at 12.0% Cu within a broader intercept of 26m at 4.1% Cu in hole SMRD-13. These new high-grade copper sulphide hits redefine the scale and geological potential of this manto-style, sediment-hosted system—something that is rarely seen in Chile. Figure 1: The location of Marimaca Copper Project near Antofagasta in northern Chile. (source: MC2) This is a material development for the company. For those who have followed Marimaca's story—particularly with its strong oxide copper foundation—the emergence of deeper sulphide potential adds a substantial new dimension to the narrative. Could this be the beginnings of a copper mining story for the company. 🔷Pampa Medina Drilling Highlights - Creating a Copper Mining Story? Marimaca’s 2025 drilling campaign at Pampa Medina has materially extended mineralisation and uncovered a potentially Tier-1 copper sulphide system (Figure 2). Figure 2: The location of Marimaca Copper Project near Antofagasta in northern Chile. (source: MC2) These are the standout results (Figure 3): 💠SMRD-13: 6m @ 12.0% Cu from 594m Within 26m @ 4.1% Cu from 580m Within 100m @ 1.3% Cu from 580m 💠SMD-02: 40m @ 2.1% Cu from 282m Within 132m @ 1.0% Cu from 278m 💠SMRD-12: 56m @ 1.4% Cu from 566m 💠SMD-01 (~600m north-west of SMD-13): 68m @ 1.2% Cu from 298m, including 20m @ 2.3% Cu 22m @ 1.7% Cu from 602m 💠SMR-01 (previously reported): 56m @ 2.1% Cu, including 18m @ 5.0% Cu from 296m Within a broader 102m @ 1.2% Cu from 250m 💠SMD-03: 42m @ 0.72% Cu from 226m Figure 3: Pampa and Step-out Drilling Locations Medina Deposit (source: MC2) These intercepts define a zone of mineralisation now traced over a 600m (E-W) x 1,000m (N-S) footprint, with potential extensions to 1.4km x 1.2km. Importantly, the copper mineralisation is hosted in flat-lying, sedimentary units with characteristics similar to Kupferschiefer or African-style deposits. 🔷 Geological and Structural Context Pampa Medina’s geology is unconventional for Chile—stratiform, sediment-hosted, high-grade copper mantos within interbedded sandstones, shales, conglomerates, and tuffs. Bornite and chalcopyrite dominate the deeper zones, while upper horizons continue to show chalcocite and oxide potential. Stratigraphic continuity between holes SMR-01, SMD-01, SMD-12, SMD-02, and SMRD-13 suggests a coherent, laterally extensive copper horizon. The sedimentary units are relatively flat-lying with a gentle easterly dip, intersected by several north-south faults which appear to influence grade and continuity. Drill core from SMRD-13 revealed intense bornite mineralisation hosted within altered black shales, suggesting a high fluid flow regime and strong stratabound control. 🔷 Implications for Development Strategy With these results, Marimaca has paused the previously announced Preliminary Economic Assessment (PEA) for Pampa Medina, as the new sulphide horizon may justify a broader-scale development concept. While the flagship MOD DFS is nearing completion—with release anticipated in the near term—management has confirmed a 14-hole follow-up program (10,000m) at Pampa Medina is already underway. Two diamond rigs are currently active on site. The proximity of Pampa Medina to MOD (28km) and to regional infrastructure (power, water, ports, workforce) makes it a natural candidate for potential integration into future production plans. Hayden Locke, President & CEO of Marimaca Copper, commented: With these thick, high-grade, sulphide intersections we now see the potential for a much larger scale copper system. Importantly, the location of Pampa Medina means it benefits from the same characteristics as our flagship MOD, such as access to first class infrastructure, proximity to workforces, lower permitting risk, and therefore any new discovery brought into development should be extremely competitive on a capital intensity basis.” “This is the first time in my 40-year career that I have seen stratiform, sediment-hosted, ultra high-grade copper in Chile of this potential scale.” — Sergio Rivera, VP Exploration Samso Concluding Comments These are the kinds of drilling results that materially alter a project’s risk/reward profile. Marimaca’s SMRD-13 intercept—6m at 12% copper—is not something you see often in Chilean copper stories. It's rare, it's stratabound, and it points to something much larger than originally anticipated. To be honest, for me, anything that is not a porphyry-related story from this part of the South American continent is new to me. I have never worked in the region nor have anything other than talking to those who have many years of experience in the region. Hence, as I cover this stock, I am learning. From a potentially stratabound-type copper deposit, the drilling results are indeed good. Some of the richest copper deposits are found in this type of copper mineralisation. Generally, this also marks a shift in how the Pampa Medina area should be viewed. What was once a complement to MOD’s oxide story could now become a significant sulphide pillar in its own right. That 600m by 1,000m footprint—with thick, high-grade zones—is more than just encouraging. Strategically, this strengthens the hub-and-spoke model Marimaca is positioning for. The flat terrain, proximity to MOD, and access to existing infrastructure reduce future capital intensity. That’s a major plus in today’s environment. If you’re looking for a story that has transitioned from a conventional oxide leach development into something with potentially district-scale sulphide upside, this is a case study. The results may still need validation through a resource update, but the directional change is clear. In the broader context of copper investment themes—grade scarcity, cost inflation, permitting hurdles—discoveries like this matter. They offer optionality, scale, and the kind of upside that can complement an already viable development story. Marimaca may still be several steps away from defining the full extent of Pampa Medina, but the direction of travel is clear. The opportunity is becoming more layered, and that’s usually a positive sign for long-term value creation. Cover photo: Native copper, malachite, and azurite - Native copper, malachite, azurite from the Black Hills, South Dakota, USA, Darla Sondrol. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Native_copper,_malachite,_and_azurite_(GeoDIL_number_-_895).jpg) The Samso Way – Seek the Research Pampa Medina is emerging as more than a satellite target—it now has the footprint, grade profile, and geological scale to potentially reposition Marimaca’s district narrative. What started as a shallow oxide exploration play now contains high-grade sulphide mantos with strong stratabound controls. For investors, this means there is now a clear dual pathway to value: the near-term MOD oxide development and the longer-term district sulphide potential led by discoveries like SMRD-13. The context of low altitude, proximity to infrastructure, and Chilean jurisdiction adds further weight. Do your own work, but this is definitely one to watch. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcements: icetana AI secures $1.7m purchase order for Middle East Safe City project icetana AI signs A$3.6m strategic partnership with SoftBank Robotics Group, including equity investment and exclusive distribution rights in Japan icetana AI March 2025 Quarterly Report The AI Surveillance Opportunity: How icetana is Scaling icetana Limited (ASX: ICE) is not a company looking to make headlines—it is one steadily building a global business in the high-growth AI surveillance sector. Headquartered in Perth and operating across six continents, icetana has developed a proprietary self-learning AI software that monitors large-scale surveillance networks in real-time. Its core value lies in recognising unusual behaviour across thousands of CCTV feeds without pre-set rules—an elegant solution for industries overwhelmed by visual data and limited human monitoring capacity. The company’s recent strategic progress includes two important developments that expand its commercial reach in Iraq and Japan. Purchase Order: Baghdad Safe City Deployment Announcement Date: 19 March 2025 Contract Value: A$1.7 million (US$1.1 million) Client: High Tech Enterprise, via Dubai subsidiary HTE Electronics Delivery Timing: Q4 FY25 In what is now icetana’s largest single contract to date, the company secured a $1.7 million software order for Iraq’s Baghdad Safe City Project. The agreement with HTE Electronics follows rigorous proof-of-concept trials where icetana’s AI solution demonstrated advanced surveillance capabilities, including: Arabic licence plate recognition Facial recognition Detection of smoke, fire, loitering, and left luggage Directional movement anomalies for people and vehicles The deal is structured around a perpetual licence (US$874,815) and a first-year maintenance agreement (US$218,660), with the latter contributing ~A$344,000 to ARR. If extended, the maintenance revenue would continue annually. CEO Kevin Brown commented: “This initial sale is the largest value contract in icetana AI’s listed history and represents a significant milestone for our company.” This contract also represents icetana’s first entry into the Iraqi market, positioning the Company to potentially support broader national Safe City rollouts in the future. Strategic Partnership: SoftBank Robotics Group Announcement Date: 7 June 2025 Total Value: A$3.6 million+ Key Components: A$1.87 million equity investment (17.6% stake at 2c/share) A$693,000 minimum ARR in Japan (12-month exclusive distributorship) A$1.08 million in R&D collaboration over 3 years In June, icetana announced a landmark strategic partnership with SoftBank Robotics Group, comprising four distinct agreements: Equity Subscription: SoftBank Robotics Singapore acquired 93.6 million shares at $0.02, representing a 33% premium to the 15-day VWAP. Exclusive Distribution in Japan: A 12-month exclusivity period with a guaranteed revenue floor of US$450,000, aimed at scaling adoption through SoftBank’s network. Joint Development Program: A$1.08 million in co-funded R&D to integrate icetana’s AI with SoftBank’s robotics and automation platforms. Board Rights: SoftBank reserves the right to nominate a non-executive director while holding a minimum 10% stake. This strategic foothold builds on icetana’s earlier work with Macnica, Inc., and strengthens its presence in Japan’s enterprise and public sector markets. Kevin Brown commented: “This partnership not only accelerates our expansion into key markets but also integrates our technology into some of the world’s most advanced security platforms.” Key Company Metrics – March 2025 Quarter Annual Recurring Revenue (ARR): A$1.7 million Net ARR Retention: 99% (▲1% QoQ) Total Revenue (Q3 FY25): A$435,000 Gross Margin: 81% Cash Balance (31 March 2025): A$2.24 million Average Monthly Operating Cash Outflow: ~A$220,000 Customer Cash Receipts (Q3 FY25): A$178,000 New Customer Orders (Q3): Includes A$1.7m order from High-Tech (Iraq) and Singapore’s Henderson Technology Customer Sites: 70+ globally Active Cameras Under Licence: 16,000+ Countries Deployed: 15+ What Makes icetana Different? icetana stands out by offering a self-learning AI surveillance system that requires no manual configuration and begins detecting anomalies within 24 hours. Its real-time alerts, scalability across large networks, and ability to significantly reduce false alarms make it ideal for high-demand environments. Deployed in over 75 sites across 15 countries, icetana’s flexible hardware and cloud solutions cater to industries ranging from public safety to retail and education. Figure 1: icetana AI core product, Safety and Security, connects with your existing security cameras to detect unusual or interesting events across large surveillance networks. (source: ICE) Self-Learning AI: No need for manual rule setting—icetana’s AI learns what’s “normal” for each camera within 24 hours. Real-Time Anomaly Detection: Instantly detects and alerts to unusual behaviours as they happen. No Configuration Required: Deploys quickly without complex calibration or custom setup. Scalable Across Networks: Handles thousands of camera feeds across multiple locations with ease. Reduces False Alarms: Intelligent event filtering minimises noise, helping operators focus on real threats. Hardware & Cloud Options: Offers flexible deployment—on-premise, cloud-based, or hybrid. Industry-Agnostic: Used in retail, transportation, public safety, education, hospitality, and guarding services. Proven Global Footprint: Installed across 75+ sites, 16,700+ cameras, in 15+ countries. Kevin Brown, CEO of icetana AI, commented: “Adding to our existing partnership with Macnica, this agreement with SoftBank Robotics Group represents a major step forward for icetana AI in Japan. Their global leadership in AI and commercial scale in Japan create an ideal launchpad for our next phase of growth. This partnership not only accelerates our expansion into key markets but also integrates our technology into some of the world’s most advanced security platforms.” Why the Market Is Watching The global video surveillance industry continues to expand at pace: 13.7% CAGR forecast between 2024 and 2028 1+ billion CCTV cameras deployed in 2024, projected to surpass 6 billion by 2030 Growing government investment in Safe City initiatives, critical infrastructure, and AI-enhanced public safety systems In this context, icetana is positioning itself as a high-value player in AI-enabled surveillance, offering a scalable, self-learning platform for real-time anomaly detection across complex environments. Whether it’s shopping malls, universities, transport networks, or nationwide security deployments, icetana’s enterprise-grade solution is built to operate at scale, with minimal configuration and long-term recurring value. Samso Concluding Comments icetana is not a company that I have a lot of exposure to in my investing space, but it is definitely a breath of fresh air. For me, the two deals we discussed, first with High Tech in Iraq and now with SoftBank in Japan, are impressive and should create what I call a base for expansion. Good sales deals help with potential future deals. The Baghdad Safe City contract confirms product-market fit for icetana in one of the world’s most complex environments. The SoftBank Robotics partnership, on the other hand, opens up opportunities to embed icetana’s tech into next-generation robotics platforms and create new commercial channels in Asia. With a relatively modest market cap and a strong strategic partner now sitting on the register, there’s an argument to be made that icetana may be underestimated. Samso’s not saying it’s a must-buy—but for those following the AI security space, this might be one to put on your watchlist. As always, the story is in the execution. As always, this is not a recommendation—Samso doesn’t make those. But for those watching the AI space—especially where it intersects with infrastructure, surveillance, and automation—icetana’s moves over the past few months might be worth noting. The company is still under the radar in valuation terms, yet has now found itself partnered with global names that tend to think long-term. Maybe it’s not about chasing the next big hype cycle. Maybe it’s about finding companies like this—ones that are doing the work. The Samso Way – Seek the Research Pampa Medina is emerging as more than a satellite target—it now has the footprint, grade profile, and geological scale to potentially reposition Marimaca’s district narrative. What started as a shallow oxide exploration play now contains high-grade sulphide mantos with strong stratabound controls. For investors, this means there is now a clear dual pathway to value: the near-term MOD oxide development and the longer-term district sulphide potential led by discoveries like SMRD-13. The context of low altitude, proximity to infrastructure, and Chilean jurisdiction adds further weight. Do your own work, but this is definitely one to watch. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Cover photo: CSS code on a screen (Unsplash), Sai Kiran Anagani _imkiran. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:CSS_code_on_a_screen_(Unsplash).jpg) Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement Diggers & Dealers Presentation 2025 Boss Energy Ltd (ASX: BOE) has achieved a significant operational milestone with the successful restart and ramp-up of the Honeymoon Uranium Project in South Australia (Figure 1). As one of the few new uranium producers to emerge in a tightly held global market, Boss is positioning itself as a first mover in a sector benefiting from rising long-term uranium prices, policy momentum, and expanding nuclear power infrastructure. Figure 1: Honeymoon Uranium Project in South Australia (source: BOE) 🔹 Honeymoon Uranium Project Restart – From Restart to Cashflow Positive The April 2024 restart of the Honeymoon Uranium Project marked the return of commercial uranium production from this historic South Australian operation. Now, just over a year later, Boss Energy has exceeded its FY2025 production guidance with 872,607 lbs of U₃O₈ produced, beating its original target of 850,000 lbs. Key achievements for Boss Energy at the Honeymoon Project include the declaration of commercial production in January 2025, followed by the project becoming free cash flow positive by April 2025. In the June 2025 quarter, production performance saw a marked improvement, with drummed U₃O₈ output rising by 18% and IX production increasing by 60% compared to the previous quarter. Notably, the C1 cash cost for the second half of FY2025 was reported at US$23/lb, placing Boss well below industry average and highlighting the operational efficiency of the ramp-up phase. Figure 2: NIMCIX columns 1 to 3 at nameplate capacity (source: BOE) Boss attributes this success to consistent wellfield performance and the operation of NIMCIX columns 1 to 3 at nameplate capacity, with columns 4 to 6 now practically complete and set for commissioning (Figure 2). 🔹 Wellfield Expansion and FY2026 Guidance The Company’s ramp-up strategy is gaining momentum. With three wellfields already in operation, five more (B4–B8) are scheduled to come online progressively throughout FY2026. By the end of FY2026, Boss expects all nine wellfields to be operational, supporting its production guidance of 1.6 million lbs of U₃O₈ for the year. For FY2026, Boss Energy is targeting uranium production of 1.6 million pounds of U₃O₈ from the Honeymoon Project. The Company has guided for a competitive C1 cash cost of US$27–29/lb, with an all-in sustaining cost (AISC) forecast between US$41–45/lb. To support this continued ramp-up, total capital expenditure is expected to range between A$56–62 million, including investment in new wellfields, infrastructure upgrades, and final commissioning of additional NIMCIX columns. Figure 3: NIMCIX columns 1 to 3 at nameplate capacity (source: BOE) Boss is also investing in long-term value creation through the finalisation of NIMCIX commissioning, construction of new wellfields, and enhancements to drying and packing infrastructure. Importantly, ramp-up efforts are matched by measured cost control and capital allocation. 🔹 Exploration to Sustain and Grow Production Boss is simultaneously advancing its satellite deposit strategy to underpin mine life extension. During the quarter: Infill drilling at Gould’s Dam and Jasons satellite deposits returned strong intersections, such as 3.25m @ 3,873 pU₃O₈ (WRM176) (Figure 4). Mineral Resource Estimate (MRE) updates for both deposits are scheduled for this quarter. Permitting processes for satellite deposits have commenced. Exploration at greenfield targets, including Cummins Dam, continues with passive seismic surveys and aircore drilling. Figure 4: Exploration Activities for Uranium (source: BOE) These exploration efforts are designed to convert known mineralisation into future production and leverage Honeymoon’s existing infrastructure. 🔹 Strategic Platform: Tier 1 Focus and International Growth Beyond Honeymoon, Boss Energy is building a diversified uranium production platform across tier-one jurisdictions: Alta Mesa (Texas): 30% JV stake; ramping up, with 204,000 lbs U₃O₈ produced in the recent quarter. Laramide Resources (Canada-listed): Strategic stake increased to 19.9%; includes the Westmoreland Project in Queensland (65.8M lbs U₃O₈ MRE). Alligator Rivers (NT): Earn-in agreement with Eclipse Group. Kazakhstan: 6,000 km² land position in the Chu-Sarysu Basin. 🔹 Positioned for Long-Term Uranium Price Upside Boss Energy is well-positioned to benefit from the rising long-term uranium price, which is now at an all-time high in AUD terms. With approximately 85% of uranium traded under long-term contracts, the sustained strength of this pricing mechanism—currently around US$80/lb—supports Boss Energy’s commercial production strategy and underpins strong cash flow potential from its Honeymoon and Alta Mesa operations. Figure 5: U₃O₈ Prices Since 2004 – Spot vs Long-Term (AUD) (source: BOE) Samso Concluding Comments Boss Energy’s successful restart of the Honeymoon Uranium Project in South Australia is a rare story of persistence, planning, and precision in execution. What began with a 2015 acquisition has now materialised into a cash-generating, fully operational uranium mine—one of the very few globally to reach commercial production status in recent years. In the context of rising long-term uranium prices, global policy tailwinds, and energy security concerns, Boss is no longer a speculative uranium play. It’s a proven producer with a scalable foundation. The ramp-up strategy is clear, the wellfield development is sequenced, and cash costs are competitive—this is exactly what long-term investors look for in a resource story. What also stands out is the company’s broader platform: Alta Mesa, the Laramide stake, and ongoing exploration across Australia and Kazakhstan offer Boss the kind of multi-asset, multi-jurisdictional exposure that is often spoken about, but rarely delivered at this scale from the ASX. The takeaway is simple: Boss Energy has moved out of the explorer category. Honeymoon is not a case study—it’s a case closed. The production is real, the uranium is flowing, and the balance sheet is strong. From here, it’s about scaling, securing offtakes, and staying ahead of the demand curve. For those watching the uranium sector evolve from promise to production, Boss Energy has quietly become one of the sector’s new benchmarks. Cover photo: URANIUM MILL JUST OUTSIDE OF MOAB. THE ORE COMES FROM A MINE ABOUT 25 MILES AWAY. THE REGION IS RICH IN URANIUM AND POTASH. THESE MINERALS ARE THE BASIS OF THE TWO MAJOR INDUSTRIES OF THE AREA, David Hiser. Public domain, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:URANIUM_MILL_JUST_OUTSIDE_OF_MOAB._THE_ORE_COMES_FROM_A_MINE_ABOUT_25_MILES_AWAY._THE_REGION_IS_RICH_IN_URANIUM_AND..._-_NARA_-_545611.jpg) The Samso Way – Seek the Research The uranium narrative is often driven by headlines, but value lies in the details. Boss Energy’s approach—grounded in disciplined ramp-up, tangible production metrics, and long-term infrastructure investment—exemplifies how real value is created in the resource sector. Honeymoon is no longer a future story—it’s a producing asset with momentum, and it warrants a close look from investors seeking exposure to the global nuclear revival. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and has a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.

Announcement Emyria Commences National Expansion with Avive in Brisbane Emyria Limited (ASX: EMD), a pioneer in evidence-based mental health care, has announced a strategic move into Queensland via a new agreement with Avive Health. This initiative marks the Company’s first Queensland-based clinic and a critical step in Emyria’s nationwide expansion strategy. The new clinic, to be located within Avive’s licensed 63-bed mental health hospital in Brisbane, will house an Empax Centre focused on treatment-resistant depression and Post-traumatic stress disorder (PTSD). Figure 1: The Avive mental health hospital in Brisbane features a 63-bed facility that combines a restored heritage-listed exterior with a modern, welcoming interior reception area. (source: EMD) This announcement follows closely on the heels of Emyria’s landmark reimbursement agreement with Medibank Private Ltd (ASX: MPL), underscoring a growing demand for reimbursable, specialised mental health treatments. The Brisbane clinic is expected to begin operations in Q4 CY2025, subject to approvals and fit-out completion. 1. Key Highlights - The Care for Mental Health Solution. ✅ Landmark Agreement: Emyria has secured an exclusive deal with Avive Health to launch its first Empax clinic in Queensland, specifically within Avive’s licensed Brisbane hospital. ✅ First Right of Refusal: The agreement includes first rights to expand into Avive-operated hospitals in Victoria and South Australia, supporting further national rollout. ✅ Capital-Light Expansion Model: Avive provides infrastructure and licensure, while Emyria delivers the full clinical team and Empax programs, enabling cost-effective scaling. ✅ Strategic Fit: This initiative aligns with Emyria’s Medibank agreement to deliver reimbursed psychedelic-assisted therapy and addresses high unmet needs in PTSD and treatment-resistant depression. ✅ Strong Demand & Timeline: The Brisbane clinic is expected to significantly expand patient capacity, with treatments to commence in late 2025. 2. Strategic Rationale and National Expansion Vision Mental health remains one of Australia’s most pressing chronic conditions, with PTSD affecting approximately 1 in 11 Australians and disproportionately impacting women, veterans, and first responders. Emyria’s Empax program responds to this demand with a scalable, clinically validated model that delivers real-world care while capturing actionable data to inform future therapies. This expansion into Brisbane is a major step in Emyria’s broader strategy, which includes: Opening additional Empax centres in major Eastern states. Partnering with hospital networks and insurers to support access and affordability. Expanding indications beyond PTSD and TRD. Leveraging real-world data to support regulatory and payer engagement. The partnership with Avive allows Emyria to embed its Empax protocols directly into Avive’s hospital systems, supporting integrated, high-quality care delivery. Greg Hutchinson, Emyria’s Executive Chairman, commented: “This agreement with Avive is a key milestone in our east coast expansion strategy and allows us to bring our innovative Empax model of care to patients in Queensland. Our recent agreement with Medibank was the first of its kind and strong validation of our approach, and we are now building on that momentum to expand patient access to funded, innovative mental health care, nationally.” Mark Sweeney, Co-CEO of Avive, added: “Avive is committed to becoming Australia’s leading provider of innovative, high-quality mental health care. This partnership with Emyria and the establishment of an Empax Centre within our Brisbane facility reflects our ambition to integrate cutting-edge treatments into our service offering.” Samso Concluding Comments The agreement with Avive represents more than just geographic expansion—it affirms the robustness of Emyria’s scalable, capital-efficient model. With infrastructure costs largely offset through partnerships, the Company continues to extend its clinical footprint without compromising its balance sheet. This is particularly important in the current investment climate, where capital preservation is as important as growth. For investors, Emyria’s positioning within the reimbursed mental health space, particularly through novel psychedelic-assisted therapies, sets it apart from traditional healthcare players. The alignment with a trusted insurer (Medibank) and now a growing hospital operator (Avive) brings commercial credibility to its strategy. As the mental health crisis in Australia intensifies, Emyria’s ability to provide structured, data-backed, reimbursable care gives it a real-world advantage. The forward momentum—clinically, commercially, and geographically—is clear. The Company is building its growth through deliberate partnerships and evidence-based protocols. For investors tracking next-generation healthcare platforms, Emyria offers an intriguing combination of innovation, execution, and early-stage traction. Cover photo: Medical instruments, Saltanat. CC0, via Wikimedia Commons (https://commons.wikimedia.org/wiki/File:Medical_instruments.JPG) The Samso Way – Seek the Research At Samso, we encourage readers to engage deeply with Emyria’s strategic evolution. The mental health space is not only a humanitarian priority but also a sector poised for sustained investment attention. The Company’s investor hub and consistent ASX updates offer ample transparency—do the research, ask questions, and stay informed. Our mission is simple: cut through the noise and spotlight what matters—genuine stories, grounded insights, and real opportunity. Our content is well-researched and is only created if the team sees a merit in discussing the company or concept. Investors can explore our three core platforms: Coffee with Samso Samso Insights Samso News There may be numerous paths to success in investing, but the common thread among successful individuals is that they remain committed to making informed decisions. Equip yourself with the right knowledge and tools, and you will be well on your way to achieving your financial goals. Most importantly, investors need to be absolutely diligent in understanding their own risk-reward tolerance and capabilities. Never bite off more than you can chew. As they say, Rome wasn’t built in a day, and the Great Wall stood because it took centuries to complete. The Samso Philosophy: Stay curious. Stay sharp. And remember—digging deeper always uncovers the real value. In Life, there is no such thing as a Free Lunch. Happy Investing, and the only four-letter word you need to know is DYOR. To support our independent nature of our work, please head over to our Support Page and give us a helping hand in any of the ways listed. This is a new initiate for the Samso Platform, and it was always the concept of Samso when we started this journey in 2018. Disclaimer The information or opinions provided herein do not constitute investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not take into consideration, nor have any regard to your specific investment objectives, financial situation, risk profile, tax position and particular, or unique needs and constraints. Read full Disclaimer. Share to Grow: Your Bonus Samso has just released an eBook: How to Add Value to your Share Portfolio A lesson on geological models sought by mining companies that gives insight and an understanding of which portfolios are better - and potentially more lucrative – investments. Click here to download this eBook. Download eBook If you find this article informative and useful, please help me share the information. I try and write about topics that are interesting and have the potential to be of investment value. It is not easy to find stories that fit those parameters. If you or your organisation see the benefit of what Samso is trying to achieve and have a need to share your journey, please contact me at noel.ong@samso.com.au. About Samso Samso is a trusted platform that equips dedicated investors with up-to-date industry knowledge and insights from top CEOs and thought leaders. By staying informed on business advancements and market trends, investors can enhance their financial decisions through a combination of expert guidance and their own research.